MedPath

VITEKTA

VITEKTA

Discontinued
DIN Number

02411180

Drug Class

Human

Market Date

Apr 21, 2015

Company
HC

gilead sciences canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02411180
AIG Number0154650002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AJ02 ELVITEGRAVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

ELVITEGRAVIRActive
Strength: 150 MG
Monograph: ELVITEGRAVIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.